Overview

Clinical Study to Evaluate the Efficacy and Safety of Neuronox and Botox With Essential Blepharospasm

Status:
Completed
Trial end date:
2017-07-04
Target enrollment:
0
Participant gender:
All
Summary
This clinical study evaluates the efficacy and safety of Neuronox compared with Botox in adults with essential blepharospasm.
Phase:
Phase 3
Accepts Healthy Volunteers?
Accepts Healthy Volunteers
Details
Lead Sponsor:
Medy-Tox
Treatments:
abobotulinumtoxinA
Botulinum Toxins
Botulinum Toxins, Type A
incobotulinumtoxinA
onabotulinumtoxinA
Criteria
Inclusion Criteria:

- Adults aged 18 to 75

- Subjects had to have a confirmed clinical diagnosis of essential blepharospasm
requiring treatment by injection

Exclusion Criteria:

- Subjects who underwent surgical operation

- Subjects with Neuroleptic induced blepharospasm